We are live on ! Find out more
SCM

Stamina Capital Management Portfolio holdings

AUM $13.3M
1-Year Est. Return 71.17%
This Fund
S&P 500
This Quarter Est. Return
+87.63%
1 Year Est. Return
+71.17%
3 Year Est. Return
+291.57%
5 Year Est. Return
10 Year Est. Return
AUM
$13.3M
AUM Growth
-$175M
Cap. Flow
-$183M
Cap. Flow %
-1,373.42%
Top 10 Hldgs %
100%
Holding
44
New
1
Increased
Reduced
2
Closed
41

Top Buys

Rank Stock Value
1
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$2.74M

Sector Composition

Rank Sector Weight
1 Industrials 61.12%
2 Technology 38.88%
3 Consumer Staples 0%
4 Energy 0%
5 Financials 0%

No holdings matched the selected filter criteria.

Similar funds

Stamina Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Stamina Capital Management held 44 positions worth $13.3M, down 93% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Stamina Capital Management withdrew a net $183M in Q4 2022, closing 41 positions and reducing 2 holdings. Its most notable exit was Booz Allen Hamilton, an estimated $12.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 61% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Stamina Capital Management opened a new position in Maxar Technologies Inc. Common Stock worth $5.17M.

  • Stamina Capital Management's largest Q4 2022 buy was Maxar Technologies Inc. Common Stock: 100,000 shares worth $5.17M.
  • Stamina Capital Management's biggest Q4 2022 reduction was TransDigm Group, cutting an estimated $12.5M.
  • Stamina Capital Management fully exited Booz Allen Hamilton in Q4 2022, selling an estimated $12.5M.
  • Stamina Capital Management's ten largest holdings make up 100% of its $13.3M portfolio in Q4 2022.
  • Stamina Capital Management opened 1 new position and closed 41 in Q4 2022.
  • Stamina Capital Management's portfolio value fell 93% quarter-over-quarter to $13.3M.

Based on Stamina Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.